rHuEPO


Also found in: Acronyms.

rHuEPO

recombinant human erythropoietin.
References in periodicals archive ?
These can be useful parameters to establish recent reticulocyte stimulation of reticulocytes in response to rHuEpo usage contrasting with results seen in normal physiologic RBC production.
Kirin began marketing a rHuEPO preparation, brand name ESPO(R) INJECTION, for the treatment of renal anemia in 1990, which has contributed greatly to the care of dialysis patients with renal anemia.
The general approach to detecting blood doping is to use indirect methods for screening and more specific methods for firm evidence of exogenous rHuEPO.
Very little is known about the time course of urinary rHuEPO after its administration.
Most of the exercise training studies in people with ESRD occurred before the use of rhuEPO became common.
Complications of rHuEpo use have included hypertension, clotted hemodialysis access, and, less commonly, seizures (Henna et al.
In California, Georgia, and Michigan, rHUEPO accounted for 9.
Barany, "Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress," Nephrology Dialysis Transplantation, vol.
Results of the first human trials of rHuEPO were published in 1986-1987 (Eschbach, Egrie, Downing, Browne, & Adamson, 1987; Winearls et al.